Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients
Clinical trial NCT02268526 · COMPLETED
Trial details
- NCT number
- NCT02268526
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-02
- Primary completion
- 2016-12-07
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.